|Sept. 2008-Present||Clinical Evaluation of T.R.U.E TEST(r) Panel 1.1, 2.1, and 3.1 in Children and Adolescents Allerderm.||$155,924 |
|Mar. 2008- Present|
An Investigator-Blinded, Randomized, Community, Based, Phase Four Study to Assess Facial Acne Improvement and Tolerability with Use of RETIN-A MICRO(r) (Tretinioin Gel) Microsphere, 0.04% in a Pump Dispenser in a Pediatric Population Johnson and Johnson/OrthoNeutrogena.
A Phase 2B Multi-Center, Double-Blind, Randomized, Dose-Ranging Clinical Trial to Evaluate IDP-107 in the Treatment of Moderate to Severe Acne Vulfatis with Nodular Involvement.
|Jan. 2008-Present||A Randomized, Double-Blind, Placebo-Controlled, Dose Response Study for the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa. ||$13,048|
|June 2008-Dec. 2008||A Randomized, Double-Blind, Comparative, Crossover study to Evaluate the Tolerance and Efficacy of SS Baby Sunblock Lotion SPF 60, 1321-126 to a Commercial Benchmark Product in Babies and Children Neutrogena.||$86,499|
|June 2007-Present ||A Multi-Center, Open-Label Study to Evaluate the Effect of Altana Inc’s CutivateLotion 0.05% on the Hypothalamic Pituitary Adrenal Axis in the Treatment of Atopic Dermatitis in a Pediatric Population||$44,283|
|Oct. 2007- Present||Method Evaluation for Buccal Swab Collection - a substudy of CASM981C US09 Novartis (Amendment#2 Fillagrin).||$18,175|
|Oct. 2007-Present||A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Adapalene Lotion, 0.1% Compared with Vehicle Lotion in Subjects with Acne Vulgaris.||$123,543|
|Aug. 2007-Present||Evaluation of the Cutaneous Innate Immune and Clinical Response to Oral and Topical Vitamin D UCSD/CSSD/RCHSD Intramural Grant.||$50,000|
|Jan. 2006-Present||An Open-label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects with Plaque Psoriasis.||$251,799.98|
|Dec. 2006-Present||A Placebo-Controlled, Double-blind, Randomized Parallel Group Exploratory Study of the Safety and Efficacy of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis That is Moderate in Severity.||$85,477 |
|Dec. 2006- Present||PK and PD of Calcitriol Following Twice Daily Application of Calcitriol 3µg/g Ointment under Conditions of Maximal Use on Adolescents with Plaque Psoriasis RD.06.SPR.18102/Galderma.||$101,321|
|Jan. 2006- Present||A Prospective Pediatric Longitudinal Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis APPLES/Astellas.||$19,000|
|Dec. 2005-Present||A 5-year Prospective Study in Infants with Atopic Dermatitis to Determine Risk Factors, with a Focus on Pets and Pests, on the Development of Asthma and Allergic Diseases CASM981C US26/Novartis.||$11,907|
|Apr. 2002- Present||An Investigation of the Safety and Efficacy of Elidel 1% Cream in Atopic Disease Modification, Assessed in a 3 Year Randomized, Double-Blind, Vehicle-Controlled Phase to Evaluate effects on Atopic Dermatitis in Infants, and a 2-3 Year Open-Label Phase to Evaluate the Effect of Early Intervention Versus Delayed Intervention with Elidel on the Incidence of Asthma in Children Novartis.||$508,625|